Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE–/– mice

Saved in:
Bibliographic Details
Published inActa pharmaceutica Sinica. B Vol. 14; no. 12; pp. 5505 - 5508
Main Authors Chen, Meijie, Little, Peter J., Kong, Sudong, Banach, Maciej, Weng, Jianping, Xu, Suowen
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.12.2024
Elsevier
Subjects
ACLY
Aclysiran
Atherosclerosis
Letter to the Editor
ACLY
Atherosclerosis
Aclysiran
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2211-3835
2211-3843
DOI:10.1016/j.apsb.2024.10.008